TMED9 and glioma: Through an extensive literature review, we compiled multiple datasets related to glioma chemotherapy, which indicated significant differences in TMED9 expression when compared to a control group, including patients receiving first-line glioma treatment drugs such as temozolomide, disulfiram, and JQ1 (Figures 10C–F).